NCT00210054View on ClinicalTrials.gov

A Pharmacokinetic Evaluation Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Healthy

Interventions

DRUG

denufosol tetrasodium (INS37217)

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00210054 - A Pharmacokinetic Evaluation Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter